Financials
Financial year 2025
PIKASOMED from Le Roeulx, company number BE0788272082, closed financial year 2025 with a result of € 115,631 after tax. For that financial year PIKASOMED recorded a gross margin of € 197,716 and equity of € 402,478. Compared with financial year 2024, the result moved from € 165,149 to € 115,631. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 402,478
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 115,631
▼ 30% vs 2024
Profit after tax over the fiscal year.
€ 40,187
▲ 104% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 70,145 paid out
61 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 84,413
▲ 26% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 50,096
▼ 56% vs 2024
€ 32,187 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 4,161
▼ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 31,199
▼ 38% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 270,485 | € 219,466 | € 249,546 | € 197,716 | ▼ 21% |
| Profit after taxes | € 78,228 | € 120,370 | € 165,149 | € 115,631 | ▼ 30% |
| Equity | € 108,213 | € 228,583 | € 356,992 | € 402,478 | ▲ 13% |
| Total debts | € 261,836 | € 244,428 | € 206,043 | € 155,921 | ▼ 24% |
| Cash | € 127,639 | € 81,569 | € 19,683 | € 40,187 | ▲ 104% |
| Retained profit | € 107,241 | € 227,611 | € 356,020 | € 401,506 | ▲ 13% |
| Dividend | € 0 | € 0 | € 36,739 | € 70,145 | ▲ 91% |
| Bank debt | € 182,485 | € 176,633 | € 113,016 | € 50,096 | ▼ 56% |
| Balance sheet total | € 370,049 | € 473,011 | € 563,035 | € 558,400 | ▼ 1% |
Key figures of PIKASOMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PIKASOMED?
What happened at PIKASOMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 115,631 (▼ 30% vs 2024). Source: NBB ↗
- New establishment in Le Roeulx. KBO
- New establishment in Le Roeulx. KBO
- New establishment in Binche. KBO
- Start of the company according to the CBE. KBO
In short
From € 78,228 profit in 2022 to € 115,631 profit in 2025.
Paid € 196,331 in corporate taxes since 2022.
Best year ever: 2024, with € 165,149 profit.
Paid out € 106,884 in dividends to the owners in total.
Management
Behind PIKASOMED are Karine Claus and Pierre Leich. The same people are also behind IMMOKAPI.
Establishments
Establishment units
Physical locations of this company
Faubourg de Mignault(R) 1
7070 Le Roeulx
Chaussée de Mons(T) 1
7070 Le Roeulx
Active since 6 July 2022
Rue Carlo-Mahy(BIN) 13 box B
7130 Binche
Active since 6 July 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0788.272.082
- VAT number
- BE 0788.272.082
- Registered office
- Faubourg de Mignault(R) 1, 7070 Le Roeulx
- Names & denominations
- PIKASOMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 July 2022
- Peppol
- Active · Active since 19 Jan 2026
- Activities · NACE
Activiteiten van medisch specialisten